These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 17413976
1. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. Ali A, Black D, Soslow RA. Int J Gynecol Pathol; 2007 Apr; 26(2):115-23. PubMed ID: 17413976 [Abstract] [Full Text] [Related]
2. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma. Ismiil ND, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Thomas G, Ackerman I, Covens A, Khalifa MA. Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412 [Abstract] [Full Text] [Related]
3. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion. Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Ackerman I, Thomas G, Covens A, Khalifa MA. Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108 [Abstract] [Full Text] [Related]
4. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis. Mittal KR, Barwick KW. Gynecol Oncol; 1993 May; 49(2):197-201. PubMed ID: 8504988 [Abstract] [Full Text] [Related]
5. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion. Quick CM, May T, Horowitz NS, Nucci MR. Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347 [Abstract] [Full Text] [Related]
6. Reassessment of myometrial invasion in endometrial carcinoma. Kaku T, Tsuruchi N, Tsukamoto N, Hirakawa T, Kamura T, Nakano H. Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481 [Abstract] [Full Text] [Related]
8. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role. Espinosa I, José Carnicer M, Catasus L, Canet B, D'angelo E, Zannoni GF, Prat J. Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622 [Abstract] [Full Text] [Related]
9. MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Nakao Y, Yokoyama M, Hara K, Koyamatsu Y, Yasunaga M, Araki Y, Watanabe Y, Iwasaka T. Gynecol Oncol; 2006 Aug; 102(2):343-7. PubMed ID: 16469365 [Abstract] [Full Text] [Related]
10. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance. Murray SK, Young RH, Scully RE. Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811 [Abstract] [Full Text] [Related]
11. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Soeda S, Nakamura N, Ozeki T, Nishiyama H, Hojo H, Yamada H, Abe M, Sato A. Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648 [Abstract] [Full Text] [Related]
13. Predictors of final histology in patients with endometrial cancer. Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC. Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947 [Abstract] [Full Text] [Related]
15. Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma. Chung HH, Kang SB, Cho JY, Kim JW, Park NH, Song YS, Kim SH, Lee HP. Gynecol Oncol; 2007 Mar; 104(3):654-9. PubMed ID: 17095081 [Abstract] [Full Text] [Related]
16. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma. Stokes GN, Shelton JB, Zahn CM, Kendall BS. Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977 [Abstract] [Full Text] [Related]